Cedars-Sinai Medical Center
As an NIH-funded translational scientist and an Associate Professor at Cedars-Sinai Medical Center, Dr. Jay Kim aims to improving the means of objectively diagnosing IC/PBS and to discover the mechanistic basis for this disorder. She was originally trained as a cancer biologist at Harvard Medical School, and is a rising leader of research on basic urological diseases including IC/PBS. One of the major focus areas in her group is the study of the metabolic signature for the diagnosis of IC/PBS, using a number of approaches, including large-scale “Omics” methods, to elucidate the signaling network in human cells that is perturbed in IC/PBS.
Cancer Biology,Biomedical Sciences, surgery